# Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection

> **NCT04339426** · PHASE2 · TERMINATED · sponsor: **HonorHealth Research Institute** · enrollment: 3 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Atovaquone/Azithromycin

## Key facts

- **NCT ID:** NCT04339426
- **Lead sponsor:** HonorHealth Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-20
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-02-11
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Closed due to poor enrollment
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04339426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04339426, "Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04339426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*